Latest Insider Transactions at Isoray, Inc. (ISR)
This section provides a real-time view of insider transactions for Isoray, Inc. (ISR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Isoray, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Isoray, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2024
|
Jonathan Robert Hunt Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,800
+4.77%
|
$16,200
$9.81 P/Share
|
|
Jun 14
2024
|
Lori A Woods |
BUY
Open market or private purchase
|
Indirect |
4,587
+1.4%
|
$45,870
$10.85 P/Share
|
|
Jun 13
2024
|
Johan M. Spoor CEO |
BUY
Open market or private purchase
|
Direct |
100,000
+42.09%
|
$100,000
$1.17 P/Share
|
|
Jun 03
2024
|
Lori A Woods |
BUY
Open market or private purchase
|
Indirect |
34,246
+2.16%
|
$34,246
$1.46 P/Share
|
|
May 31
2024
|
Jonathan Robert Hunt Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
25,006
+3.59%
|
$25,006
$1.4 P/Share
|
|
May 31
2024
|
Robert F Williamson Iii |
BUY
Open market or private purchase
|
Direct |
55,000
+11.49%
|
$55,000
$1.38 P/Share
|
|
May 29
2024
|
Robert F Williamson Iii |
BUY
Open market or private purchase
|
Direct |
30,031
+3.98%
|
$30,031
$1.33 P/Share
|
|
Apr 23
2024
|
Mark John Austin VP Finance/Prin Fin&Acct Offic |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+26.31%
|
$0
$0.36 P/Share
|
|
Mar 06
2024
|
Lantheus Alpha Therapy, LLC |
BUY
Open market or private purchase
|
Direct |
60,431,039
+34.1%
|
$0
$0.95 P/Share
|
|
Jan 30
2024
|
Robert F Williamson Iii |
BUY
Open market or private purchase
|
Direct |
127,206
+7.66%
|
$0
$0.71 P/Share
|
|
Jan 29
2024
|
Robert F Williamson Iii |
BUY
Open market or private purchase
|
Direct |
25,266
+5.6%
|
$0
$0.64 P/Share
|
|
Jan 26
2024
|
Robert F Williamson Iii |
BUY
Open market or private purchase
|
Direct |
110,613
+13.72%
|
$0
$0.58 P/Share
|
|
Jan 25
2024
|
Robert F Williamson Iii |
BUY
Open market or private purchase
|
Direct |
22,134
+22.63%
|
$0
$0.49 P/Share
|
|
Jan 24
2024
|
Markus Puhlmann Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
280,000
+16.91%
|
$0
$0.5 P/Share
|
|
Jan 24
2024
|
Robert F Williamson Iii |
BUY
Open market or private purchase
|
Direct |
29,862
+35.8%
|
$0
$0.49 P/Share
|
|
Dec 21
2023
|
Robert F Williamson Iii |
BUY
Open market or private purchase
|
Indirect |
3,663
+50.0%
|
$0
$0.33 P/Share
|
|
Dec 19
2023
|
Robert F Williamson Iii |
BUY
Open market or private purchase
|
Direct |
13,680
+36.62%
|
$0
$0.32 P/Share
|
|
Dec 19
2023
|
Markus Puhlmann Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
400,000
+26.75%
|
$0
$0.34 P/Share
|
|
Dec 18
2023
|
Robert F Williamson Iii |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$0
$0.26 P/Share
|
|
Dec 18
2023
|
Jonathan Robert Hunt Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
125,000
+28.3%
|
$0
$0.26 P/Share
|
|
Dec 18
2023
|
Markus Puhlmann Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
60,419
+7.99%
|
$0
$0.26 P/Share
|
|
Dec 15
2023
|
Markus Puhlmann Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
135,006
+17.53%
|
$0
$0.27 P/Share
|
|
Dec 15
2023
|
Lori A Woods |
BUY
Open market or private purchase
|
Indirect |
152,962
+9.14%
|
$0
$0.27 P/Share
|
|
Dec 14
2023
|
Lori A Woods |
BUY
Open market or private purchase
|
Indirect |
32,238
+2.3%
|
$0
$0.27 P/Share
|
|
Apr 17
2023
|
Lori A Woods |
BUY
Exercise of conversion of derivative security
|
Indirect |
23,566
+1.74%
|
$0
$0.61 P/Share
|
|
Apr 13
2023
|
Lori A Woods |
BUY
Exercise of conversion of derivative security
|
Indirect |
163,934
+11.11%
|
$0
$0.61 P/Share
|
|
Dec 05
2022
|
Jonathan Robert Hunt Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
32,200
+14.38%
|
$0
$0.38 P/Share
|
|
Dec 01
2022
|
Jonathan Robert Hunt Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
53,204
+25.01%
|
$0
$0.38 P/Share
|
|
Nov 15
2022
|
Lori A Woods |
BUY
Open market or private purchase
|
Indirect |
100,000
+8.02%
|
$0
$0.34 P/Share
|
|
Aug 18
2022
|
Jennifer Streeter COO & VP of HR |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+36.25%
|
$0
$0.43 P/Share
|
|
Aug 05
2022
|
Jennifer Streeter COO & VP of HR |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+44.61%
|
$0
$0.33 P/Share
|
|
Jun 09
2022
|
Mark John Austin VP Finance/Prin Fin&Acct Offic |
BUY
Open market or private purchase
|
Direct |
13,800
+20.35%
|
$0
$0.29 P/Share
|
|
Jun 08
2022
|
Mark John Austin VP Finance/Prin Fin&Acct Offic |
BUY
Open market or private purchase
|
Direct |
5,000
+11.05%
|
$0
$0.28 P/Share
|
|
Jun 08
2022
|
Jonathan Robert Hunt Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
25,675
+19.45%
|
$0
$0.29 P/Share
|
|
Jun 07
2022
|
Jonathan Robert Hunt Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
13,325
+14.18%
|
$0
$0.28 P/Share
|
|
Jun 07
2022
|
Lori A Woods |
BUY
Open market or private purchase
|
Indirect |
75,000
+6.68%
|
$0
$0.3 P/Share
|
|
Nov 23
2021
|
Lori A Woods |
BUY
Exercise of conversion of derivative security
|
Indirect |
125,000
+6.24%
|
$0
$0.45 P/Share
|
|
Mar 12
2021
|
Lori A Woods |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
24,038
+2.76%
|
$0
$0.57 P/Share
|
|
Mar 12
2021
|
Lori A Woods |
BUY
Exercise of conversion of derivative security
|
Indirect |
212,500
+6.66%
|
$0
$0.53 P/Share
|
|
Nov 30
2020
|
Lori A Woods |
BUY
Open market or private purchase
|
Indirect |
68,000
+10.02%
|
$0
$0.38 P/Share
|
|
Oct 22
2020
|
Lori A Woods |
BUY
Open market or private purchase
|
Direct |
48,076
+50.0%
|
$0
$0.52 P/Share
|
|
Oct 22
2020
|
Philip J Vitale Director |
BUY
Open market or private purchase
|
Indirect |
20,000
+13.33%
|
$0
$0.52 P/Share
|
|
Oct 22
2020
|
Alan Hoffmann Director |
BUY
Open market or private purchase
|
Direct |
19,230
+50.0%
|
$0
$0.52 P/Share
|
|
Oct 22
2020
|
Michael W Mc Cormick Director |
BUY
Open market or private purchase
|
Direct |
19,230
+31.81%
|
$0
$0.52 P/Share
|
|
Oct 22
2020
|
William Cavanagh Chief R&D Officer |
BUY
Open market or private purchase
|
Direct |
7,692
+21.74%
|
$0
$0.52 P/Share
|
|
Oct 22
2020
|
Jonathan Robert Hunt Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
67,306
+50.0%
|
$0
$0.52 P/Share
|
|
Oct 22
2020
|
Michael Krachon EVP of Sales & Marketing |
BUY
Open market or private purchase
|
Direct |
28,844
+25.6%
|
$0
$0.52 P/Share
|
|
Oct 22
2020
|
Mark John Austin VP Finance/Prin Fin&Acct Offic |
BUY
Open market or private purchase
|
Direct |
19,230
+35.31%
|
$0
$0.52 P/Share
|
|
Feb 03
2020
|
Lori A Woods |
BUY
Exercise of conversion of derivative security
|
Indirect |
262,500
+16.14%
|
$0
$0.5 P/Share
|
|
Nov 20
2019
|
Michael Krachon EVP of Sales & Marketing |
BUY
Open market or private purchase
|
Indirect |
50,000
+50.0%
|
$0
$0.39 P/Share
|